GlassScriptPrepare for your visit
Ryan S Borress
Otolaryngology · Poughkeepsie, NY · NPI 1649399320
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,497.53
in general payments reported to CMS, 2019-2025 · $946 in 2025
The $946 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Who reported paying
General payments only, top 6 by amount.
- Glaxosmithkline, LLC. $891.32
- Genzyme Corporation $618.43
- Optinose US, INC. $368.25
- Acclarent, INC $342.86
- Regeneron Healthcare Solutions, INC. $342.80
- Inspire Medical Systems, INC. $130.48
Drugs and devices associated with these payments
Dupixent Nucala Xhance Inspire Pteye Parathyroid Detection System Neffy Trelegy Ellipta Auvi-Q Acclarent Aera Rhinaer Stylus Vivaer Stylus Trudi Nav Cable
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ryan Borress listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/256087/ryan-s-borress